Discover 1,296 paid clinical trials in Gilbert, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,296
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: Phoenix AZ, Orange CA, Los Angeles CA, Murray UT,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase 3, Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Location: Phoenix AZ, Redlands CA, Torrance CA, Santa Barbara CA,
Sponsor: University of British Columbia
Sex: All
Age: 0+
Code: NCT04634240
Recruiting
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Phoenix AZ, Orange CA, Rochester MN, Nashville TN,
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06375044
Phase 1, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Phoenix AZ, Tucson AZ, Cerritos CA, Los Angeles CA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Phoenix AZ, Irvine CA, Los Angeles CA, Aurora CO,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Location: Phoenix AZ, Rochester MN, Jacksonville FL
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT00830557
Recruiting
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
for
Leiomyosarcoma
Location: Phoenix AZ, Santa Monica CA, Seattle WA, Saint Louis MO,
Sponsor: Philogen S.p.A.
Sex: All
Age: 16 - 70+
Code: NCT03420014
Phase 2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Phoenix AZ, Las Vegas NV, San Diego CA, Duarte CA,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Pompe Pregnancy Sub-Registry
for
Glycogen Storage Disease Type II (GSD-II),
Location: Phoenix AZ, Iowa City IA, St Louis MO, Indianapolis IN,
Sponsor: Genzyme, a Sanofi Company
Sex: Female
Age: 0+
Code: NCT00567073
Recruiting
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Phoenix AZ, San Diego CA, La Jolla CA, Encinitas CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500481
Phase 3, Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
for
Advanced Lung Cancer
Location: Phoenix AZ, Los Angeles CA, Beverly Hills CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06892548
Phase 1, Phase 2, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Phoenix AZ, Kingman AZ, Albuquerque NM, Irvine CA,
Location: Chandler AZ, Albuquerque NM, La Jolla CA, Torrance CA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
for
Advanced Cancer, Metastatic Cancer
Location: Phoenix AZ, Los Angeles CA, Dallas TX, Rochester MN,
Sponsor: Qurient Co., Ltd.
Sex: All
Age: 18+
Code: NCT05394103
Phase 1, Phase 2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations